Skip to content

Cardiovascular Effects of Preferred Home-based Exercise Training in Systolic Heart Failure

Cardiovascular Effects of Preferred Home-based Exercise Training and Extended Adherence Measures in Systolic Heart Failure - Pilot Study

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02051712
Acronym
HOMEX-HF-P
Enrollment
120
Registered
2014-01-31
Start date
2014-02-28
Completion date
2024-12-31
Last updated
2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

chronic heart failure, exercise training, preferred training, prevention

Brief summary

The aim of the study is I. To assess whether an individualized exercise training program is superior as compared to usual care with respect to exercise tolerance, II. to assess whether intervention tools that aim to increase exercise adherence are superior to an individualized exercise training alone with respect to exercise tolerance and long-term effects, and III. to identify biomarkers that that may be implemented into novel intervention tools aiming to increase exercise adherence in patients with chronic heart failure.

Interventions

BEHAVIORALexercise training

individualized exercise training

BEHAVIORALAdherence measures

Measures to increase adherence to exercise training

Sponsors

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
CollaboratorOTHER
University Medicine Greifswald
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* women and men * age 30-75 years * chronic heart failure (NYHA II/III), left ventricular ejection fraction ≤40% be echo * disease duration ≥ 6 month * medical therapy accruing to guidelines (drug, devices, including CRT) * written informed consent

Exclusion criteria

* acute myocarditis * instable angina * heart surgery (e.g. ICD implantation, bypass) with last 6 weeks; CRT implantation within the last 6 months before study start * severe cardiovascular events (myocardial infarction, cardiac decompensation, ICD shock, PCI due to instable angina) \< 6 weeks before study start * preplanned hospital admission or intervention (e.g. planned revascularization, ICD implantation) * uncorrected valve regurgitation or stenosis (\> second degree) * safety concerns regarding or other reasons against exercise training * severe depression * regular exercise training within the last 6 weeks * life expectancy \< 1 year

Design outcomes

Primary

MeasureTime frameDescription
VO2@ATMonth 9Change of cardiopulmonary exercise tolerance from baseline to 9 month follow-up measured by exercise testing: oxygen uptake at anaerobic threshold per kg body weight (METs)

Secondary

MeasureTime frameDescription
Training adherence9, 12, 18 and 24 monthAdherence to training sessions

Other

MeasureTime frameDescription
AE9, 12, 18 and 24 monthAdverse events, related and unrelated to exercise training

Countries

Germany

Contacts

Primary ContactMarcus Dörr, MD
mdoerr@uni-greifswald.de+49 3834 8680500
Backup ContactStepahn B Felix, MD
felix@uni-greifswald.de+4938348680500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026